title: Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid.
abstract: Although chronic inflammatory reactions have been proposed to cause neuronal degeneration associated with Alzheimer's disease (AD), the role of prostaglandins (PGs), one of the secretory products of inflammatory reactions, in degeneration of nerve cells has not been studied. Our initial observation that PGE1-induced differentiated neuroblastoma (NB) cells degenerate in vitro more rapidly than those induced by RO20-1724, an inhibitor of cyclic nucleotide phosphodiesterase, has led us to postulate that PGs act as a neurotoxin. This study has further investigated the effects of PGs on differentiated NB cells in culture. Results showed that PGA1 was more effective than PGE1 in causing degeneration of differentiated NB cells as shown by the cytoplasmic vacuolation and fragmentation of soma, nuclei, and neurites. Because increased levels of ubiquitin and beta-amyloid have been implicated in causing neuronal degeneration, we studied the effects of PGs on the levels of these proteins during degeneration of NB cells in vitro by an immunostaining technique, using primary antibodies to ubiquitin and beta-amyloid. Results showed that PGs increased the intracellular levels of ubiquitin and beta-amyloid prior to degeneration, whereas the degenerated NB cells had negligible levels of these proteins. These data suggest that PGs act as external neurotoxic signals which increase levels of ubiquitin and beta-amyloid that represent one of the intracellular signals for initiating degeneration of nerve cells.
authors.affiliation: Center for Vitamins and Cancer Research, Department of Radiology, School of Medicine, University of Colorado Health Sciences Center, Denver 80262-0278, USA.
authors.forename: K N
authors.initials: KN
authors.lastname: Prasad
authors.forename: F G
authors.initials: FG
authors.lastname: La Rosa
authors.forename: J E
authors.initials: JE
authors.lastname: Prasad
mesh_terms: D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D000527:Alprostadil / Q000633:toxicity*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D016895:Culture Media, Serum-Free; D051379:Mice; D009447:Neuroblastoma; D009498:Neurotoxins / Q000633:toxicity*; D011454:Prostaglandins A / Q000633:toxicity*; D013194:Staining and Labeling; D014407:Tumor Cells, Cultured; D014452:Ubiquitins / Q000378:metabolism*
chemical_list: D016229:Amyloid beta-Peptides; D016895:Culture Media, Serum-Free; D009498:Neurotoxins; D011454:Prostaglandins A; D014452:Ubiquitins; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D003994:Bucladesine; D000527:Alprostadil; C100573:prostaglandin A1